sorafenib has been researched along with phytochlorin in 2 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (phytochlorin) | Trials (phytochlorin) | Recent Studies (post-2010) (phytochlorin) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 682 | 5 | 516 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel Gaber, SA; Abdel Kader, MH; Hüttenberger, D; Müller, P; Stepp, H; Wittig, R; Zimmermann, W | 1 |
| Balalaeva, IV; Krysko, DV; Mishchenko, TA; Vedunova, MV | 1 |
2 other study(ies) available for sorafenib and phytochlorin
| Article | Year |
|---|---|
ABCG2-mediated suppression of chlorin e6 accumulation and photodynamic therapy efficiency in glioblastoma cell lines can be reversed by KO143.
Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; Cell Line, Tumor; Cell Survival; Chlorophyllides; Diketopiperazines; Doxycycline; Gene Expression; Glioblastoma; Heterocyclic Compounds, 4 or More Rings; Humans; Light; Niacinamide; Phenylurea Compounds; Photosensitizing Agents; Porphyrins; Sorafenib | 2018 |
Ferroptosis and Photodynamic Therapy Synergism: Enhancing Anticancer Treatment.
Topics: Animals; Carbolines; Cell Line, Tumor; Chlorophyllides; Ferroptosis; Humans; Mice; Nanoparticle Drug Delivery System; Neoplasms; Photochemotherapy; Photosensitizing Agents; Piperazines; Reactive Oxygen Species; Sorafenib; Treatment Outcome | 2021 |